FluoGuide enrols first patient in US brain cancer trial

2026-10-07 10:03:00

FluoGuide has started enrolment in its US phase II trial of FG001 in high-grade glioma. It is the company’s first trial under its US IND, and a step on the road towards approval in the US. The news comes days after FluoGuide signed a collaboration agreement with microscope maker Leica Microsystems focused on the same indication.

Read the full article at biostock.se:
https://biostock.se/en/2026/10/fluoguide-enrols-first-patient-in-us-brain-cancer-trial/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Read the latest news, keep track of upcoming events, explore BioStock Analytics' in-depth analyses and watch the latest videos! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook! 

About BioStock
BioStock is the Nordic region's leading information channel for life science. Focusing on biotech, medtech, diagnostics and pharmaceutical development, we provide daily news updates, in-depth analyses via BioStock Analytics, exclusive interviews and innovation-driving networking events – all to keep you up to date on developments in the sector.
BioStock – Connecting Innovation & Capital.